183 related articles for article (PubMed ID: 38656242)
1. Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer.
Peng S; Huang H; Chen J; Ding X; Zhu X; Liu Y; Chen L; Lu Z
Technol Cancer Res Treat; 2024; 23():15330338241248573. PubMed ID: 38656242
[No Abstract] [Full Text] [Related]
2. Impact of severe-to-very severe chronic obstructive pulmonary disease on the prognosis of patients with non-small cell lung cancer who received chemotherapy.
Dong W; Zhu Y; Du Y; Wang L; Feng X; Ma S
Clin Respir J; 2020 Apr; 14(4):345-352. PubMed ID: 31876095
[TBL] [Abstract][Full Text] [Related]
3. High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non-small cell lung cancer.
Tone M; Izumo T; Awano N; Kuse N; Inomata M; Jo T; Yoshimura H; Minami J; Takada K; Miyamoto S; Kunitoh H
Thorac Cancer; 2019 Oct; 10(10):2006-2012. PubMed ID: 31482678
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
[TBL] [Abstract][Full Text] [Related]
5. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.
DeBolt CA; Bianco A; Limaye MA; Silverstein J; Penfield CA; Roman AS; Rosenberg HM; Ferrara L; Lambert C; Khoury R; Bernstein PS; Burd J; Berghella V; Kaplowitz E; Overbey JR; Stone J
Am J Obstet Gynecol; 2021 May; 224(5):510.e1-510.e12. PubMed ID: 33221292
[TBL] [Abstract][Full Text] [Related]
6. Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.
Seon JY; Jeon WH; Bae SC; Eun BL; Choung JT; Oh IH
J Korean Med Sci; 2021 May; 36(20):e148. PubMed ID: 34032033
[TBL] [Abstract][Full Text] [Related]
7. Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD.
Dong W; Du Y; Ma S
Int J Chron Obstruct Pulmon Dis; 2018; 13():3805-3812. PubMed ID: 30538442
[TBL] [Abstract][Full Text] [Related]
8. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
[TBL] [Abstract][Full Text] [Related]
9. Digestive system involvement and clinical outcomes among COVID-19 patients: A retrospective cohort study from Qatar.
Khan MU; Mushtaq K; Alsoub DH; Iqbal P; Ata F; Chaudhry HS; Iqbal F; Balaraju G; Maslamani MAA; Varughese B; Singh R; Ejji KA; Kaabi SA; Kamel YM; Butt AA
World J Gastroenterol; 2021 Dec; 27(46):7995-8009. PubMed ID: 35046626
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of bevacizumab for unresectable non-small-cell lung cancer: a meta-analysis.
Yang K; Wang YJ; Chen XR; Chen HN
Clin Drug Investig; 2010; 30(4):229-41. PubMed ID: 20225906
[TBL] [Abstract][Full Text] [Related]
12. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
13. Influence of androgen deprivation therapy on the severity of COVID-19 in prostate cancer patients.
Jiménez-Alcaide E; García-Fuentes C; Hernández V; De la Peña E; Pérez-Fernández E; Castro A; Caballero-Perea B; Guijarro A; Llorente C
Prostate; 2021 Dec; 81(16):1349-1354. PubMed ID: 34517429
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
[TBL] [Abstract][Full Text] [Related]
15. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
16. Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study.
Shionoya Y; Taniguchi T; Kasai H; Sakuma N; Imai S; Shikano K; Takayanagi S; Yahaba M; Nakada TA; Igari H; Sakao S; Suzuki T
PLoS One; 2021; 16(9):e0256977. PubMed ID: 34473766
[TBL] [Abstract][Full Text] [Related]
17. Obesity in patients with COVID-19: a systematic review and meta-analysis.
Huang Y; Lu Y; Huang YM; Wang M; Ling W; Sui Y; Zhao HL
Metabolism; 2020 Dec; 113():154378. PubMed ID: 33002478
[TBL] [Abstract][Full Text] [Related]
18. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.
van Marcke C; Honoré N; van der Elst A; Beyaert S; Derouane F; Dumont C; Aboubakar Nana F; Baurain JF; Borbath I; Collard P; Cornélis F; De Cuyper A; Duhoux FP; Filleul B; Galot R; Gizzi M; Mazzeo F; Pieters T; Seront E; Sinapi I; Van den Eynde M; Whenham N; Yombi JC; Scohy A; van Maanen A; Machiels JP
BMC Cancer; 2021 May; 21(1):578. PubMed ID: 34016086
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study.
Guarneri V; Bassan F; Zagonel V; Milella M; Zaninelli M; Cattelan AM; Vianello A; Gori S; Aprile G; Azzarello G; Chiari R; Favaretto A; Oliani C; Scola A; Pastorelli D; Mandarà M; Zustovich F; Bernardi D; Chiarion-Sileni V; Morandi P; Toso S; Di Liso E; Ziampiri S; Caccese M; Zampiva I; Puccetti O; Celestino M; Dieci MV; Conte P;
Eur J Cancer; 2021 Apr; 147():120-127. PubMed ID: 33647547
[TBL] [Abstract][Full Text] [Related]
20. Association of obesity with illness severity in hospitalized patients with COVID-19: A retrospective cohort study.
Suresh S; Siddiqui M; Abu Ghanimeh M; Jou J; Simmer S; Mendiratta V; Russell S; Al-Shammari M; Chatfield A; Alsheik E; Dang D; Genaw J; Zuchelli T
Obes Res Clin Pract; 2021; 15(2):172-176. PubMed ID: 33653666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]